Načítá se...

Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer

Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer (Auckl)
Hlavní autoři: Lousberg, Laurence, Jerusalem, Guy
Médium: Artigo
Jazyk:Inglês
Vydáno: Libertas Academica 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214808/
https://ncbi.nlm.nih.gov/pubmed/28096680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S12443
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!